Funder: Health Resources in Action
Due Dates (Anticipated): November 2026 (Invited Full Proposal deadline, projected)
Funding Amounts: Up to $500,000 total over 2 years ($250,000/year); typically 5 awards per cycle; no indirect costs allowed.
Summary: Supports innovative drug discovery research to advance new therapies for Alzheimer’s disease, focused on preclinical validation and testing of target compounds and therapeutic agents.
Key Information: Invitation required for full proposal; faculty appointment at a US non-profit institution is mandatory.